Product Development to Realize New Value
First written in FY2016. 27 of 34 entries say "Advanced", first in FY2017. Latest entry: 2026-10-01.
24 other companies' latest entry also says "Advanced".
- 2026-10-01Advancedwww.dempa-times.co.jp
「The conversion efficiency is as high as 98.6% (with a rated output capacity of 3 kVA), reducing power consumption and CO2 emissions and contributing to the achievement of the SDGs.」
The report covered the new product's specific performance and environmental specifications, indicating progress in product development. - FY2026AdvancedAnnual report
「Group-wide research and development expenses for the consolidated fiscal year, including development costs capitalized as intangible assets, were ¥3,368 million. Developed and launched 49 new products.」
Developed and launched 49 new products over the five-year period of the Ninth Medium-Term Management Plan, and recorded research and development expenses of ¥3,368 million in the consolidated fiscal year. - FY2025AdvancedAnnual report
「Developed and launched 7 new products.」
Developed and launched 7 new products during the consolidated fiscal year. Research and development expenses were ¥3,455 million, and joint research with Nagano National College of Technology also began. - FY2025-H1RestatedAnnual report
「Group-wide research and development expenses for the interim consolidated accounting period, including development costs capitalized as intangible assets, were ¥1,752 million.」
Recorded research and development expenses of ¥1,752 million and continued investing in product development. - FY2024AdvancedAnnual report
「Developed 9 new products, meeting new needs such as high-performance server applications and automation in agriculture and fisheries.」
Developed 9 new products during the consolidated fiscal year, addressing new applications including high-performance servers and automation in agriculture and fisheries. Research and development expenses were ¥3,544 million. - FY2024-Q3RestatedAnnual report
「Group-wide research and development expenses for the cumulative third quarter, including development costs capitalized as intangible assets, were ¥2,703 million.」
Also recorded research and development expenses of ¥2,703 million for the cumulative third quarter and continued investing in product development. - FY2024-Q2RestatedAnnual report
「Group-wide research and development expenses for the cumulative second quarter, including development costs capitalized as intangible assets, were ¥1,810 million.」
Disclosed research and development expenses of ¥1,810 million and continued investing in product development. - FY2024-Q1RestatedAnnual report
「Group-wide research and development expenses for the first quarter, including development costs capitalized as intangible assets, were ¥899 million.」
Recorded first-quarter research and development expenses of ¥899 million and continued investing in product development. - FY2023AdvancedAnnual report
「Developed 11 new products, meeting new needs from the precision measuring equipment and medical equipment industries.」
Developed and launched 11 new products during the consolidated fiscal year, addressing new needs in the precision measuring equipment and medical equipment industries. Research and development expenses also totaled ¥3,477 million. - FY2023-Q3RestatedAnnual report
「Group-wide research and development expenses for the cumulative third quarter, including development costs capitalized as intangible assets, were ¥2,569 million.」
Disclosed research and development expenses of ¥2,569 million and continued investing in product development. - FY2023-Q2AdvancedAnnual report
「Group-wide research and development expenses for the cumulative second quarter, including development costs capitalized as intangible assets, were ¥1,708 million.」
Disclosed research and development expenses of ¥1,708 million for the cumulative second quarter and continued investing in product development. - FY2023-Q1AdvancedAnnual report
「Group-wide research and development expenses for the first quarter, including development costs capitalized as intangible assets, were ¥871 million.」
Disclosed first-quarter research and development expenses of ¥871 million and continued investing in product development. - FY2022-Q3AdvancedAnnual report
「Group-wide research and development expenses for the cumulative third quarter, including development costs capitalized as intangible assets, were ¥2,366 million.」
Disclosed research and development expenses of ¥2,366 million for the cumulative third quarter and continued investing in product development. - FY2022-Q2AdvancedAnnual report
「Group-wide research and development expenses for the cumulative second quarter, including development costs capitalized as intangible assets, were ¥1,574 million.」
Disclosed research and development expenses of ¥1,574 million for the cumulative second quarter and continued investing in product development. - FY2022-Q1AdvancedAnnual report
「Group-wide research and development expenses for the first quarter, including development costs capitalized as intangible assets, were ¥813 million.」
Recorded ¥813 million in research and development expenses, quantifying investment in product development. - FY2021AdvancedAnnual report
「Developed 75 new products, meeting new needs from a range of industries, including precision measuring equipment and medical equipment.」
Developed 75 new products over the five-year period of the Eighth Medium-Term Management Plan and advanced efforts to address emerging industry needs. - FY2020AdvancedAnnual report
「We developed 14 new products to meet new needs from the precision measuring equipment and medical equipment industries. We will continue to actively pursue product development that anticipates customer needs.」
During the consolidated fiscal year, 14 new products were developed to address new industry needs. - FY2020-Q3AdvancedAnnual report
「The Group’s research and development expenses for the cumulative third-quarter consolidated period, including development costs capitalized as intangible assets, were ¥2,289 million.」
R&D expenses for the cumulative third-quarter consolidated period were disclosed as ¥2,289 million, quantifying the investment in product development. - FY2017AdvancedAnnual report
「We developed products including the San Ace 92, a high-airflow counter-rotating fan in a new size that provides efficient cooling; the low-power-consumption San Ace 120 fan; and the San Ace C175 high-airflow centrifugal fan, which provides high cooling performance.」
Several new product names are identified, describing specific progress in product development, including improved cooling performance, lower power consumption and new sizes. - FY2016First statedAnnual report
「Develop products that make new dreams a reality.」
New product development is presented as a growth driver alongside market expansion in the Mid-Term Management Plan’s key policies.